title: Nutlin-3 differentially modulates miRNA34a and miRNA181 versus miR26a and miR155 in p53 proficient and p53 deficient B chronic lymphocytic leukemia (B-CLL) samples.
authors.affiliation: Department of Morphology and Embryology and LTTA Centre, University of Ferrara, Ferrara, Italy.
authors.forename: Maria Grazia
authors.initials: MG
authors.lastname: di Iasio
authors.forename: Riccardo
authors.initials: R
authors.lastname: Addobbati
authors.forename: Oriano
authors.initials: O
authors.lastname: Radillo
authors.forename: Rebecca
authors.initials: R
authors.lastname: Voltan
mesh_terms: D015536:Down-Regulation / Q000187:drug effects; D020869:Gene Expression Profiling; D015973:Gene Expression Regulation, Leukemic / Q000187:drug effects*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000235:genetics*; D035683:MicroRNAs / Q000235:genetics* / Q000378:metabolism; D010879:Piperazines / Q000494:pharmacology*; D051736:Proto-Oncogene Proteins c-mdm2 / Q000378:metabolism; D016159:Tumor Suppressor Protein p53 / Q000172:deficiency* / Q000378:metabolism*
chemical_list: D007093:Imidazoles; D035683:MicroRNAs; D010879:Piperazines; D016159:Tumor Suppressor Protein p53; C482205:nutlin 3; C497206:MDM2 protein, human; D051736:Proto-Oncogene Proteins c-mdm2